Product
Feature
Quick Research
Generate reliable direction feasibility study reports for your R&D in just a few steps.
Technical Q&A
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
Find Solutions
As an expert in R&D theories, this can generate solutions to your technical problems instantly.
Evaluate Feasibility
Analyze your overall solution with one click, know your potential R&D risks in advance.
Monitor Landscape
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
164 results about "Pharmaceutical Plants" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Plants containing an active ingredient(s) with applications for medicinal purposes.
Advanced catalysts for fine chemical and pharmaceutical applications
A catalyst comprising a plurality of support nanoparticles and a plurality of catalytic nanoparticles. At least one catalytic nanoparticle is bonded to each support nanoparticle. The catalytic particles have a size and a concentration, wherein a first configuration of the size and the concentration of the catalytic nanoparticles enables a first catalysis result and a second configuration of the size and the concentration of the catalytic nanoparticles enables a second catalysis result, with the first and second configurations having a different size or concentration, and the first and second catalysis results being different. In some embodiments, the first catalysis result is a selective reduction of a first selected functional group without reducing one or more other functional groups, and the second catalysis result is a selective reduction of a second selected functional group without reducing one or more other functional groups.
Owner:SDC MATERIALS
Process for the preparation of a solid dosage form, in particular a tablet, for pharmaceutical use and process for the preparation of a precursor for a solid dosage form, in particular a tablet
Process for preparing a powder comprising the steps of providing at least one first component in liquid form at ambient temperature, providing at least one second component having a melting point or melting range in the range from above ambient temperature to below the degradation temperature of said first component, forming a homogenous liquid mixture comprising the at least one first component and the at least one second component by stirring and heating the mixture to or keeping the mixture at a temperature in the range from above the melting point or melting range of the second component and below the degradation temperature of the first component, transferring the liquid mixture to at least one spray congealing unit, spray congealing the mixture, and isolating the powder obtained upon spray congealing.
Owner:GRUNENTHAL GMBH
Spiro compounds and pharmaceutical use thereof
ActiveUS20090170908A1Impaired glucose toleranceImpaired fasting glucoseBiocideSenses disorderSpiro compoundPharmaceutical Plants
The Spiro compound represented by the following general formula [Ia], its pharmaceutically acceptable salt or a solvate thereof
Owner:JAPAN TOBACCO INC
Cultivating material for edible fungus and its production technology
InactiveCN100999428AHas disinfection and antibacterial effectReduce financial burdenSuperphosphatesUrea compound fertilisersPhosphoric acidBio engineering
This invention involves a mushroom cultivation material and production process, it belongs to the field of bio-engineering technology. This mushroom cultivation material contains Chinese crud drug residue 30 ~ 40 share, cotton shells 50 ~ 60 share, urea 1 ~ 2 share, wheat bran 5 ~ 7 share, potassium sulfate 0.5 to 1.5 share, calcium superphosphate 0.5 to 1.2 share, zinc sulfate, magnesium sulfate, borax, ferrous sulfate together for 0.4~1 share, calcined lime 0.5 to1.3 share. Because of using materials containing substances such as Chinese crud drug residue, the produced mushroom cultivation material of this invention has antibacterial effect. Through the implementation of the invention reached so no longer waste residue cause environmental pollution, reduce the factory heavy economic burden caused by the sewage problem.
Owner:王贤
Pharmaceutical use of substituted amides
InactiveUS20100087543A1Decreased intracellular concentrationImpaired glucose toleranceBiocideOrganic active ingredientsDiseaseMedical disorder
The use of substituted amides for modulating the activity of 11β-hydroxysteroid dehydro-genase type 1 (11βHSD1) and the use of these compounds as pharmaceutical composi-tions, are described. Also a novel class of substituted amides, their use in therapy, phar-maceutical compositions comprising the compounds, as well as their use in the manufac-ture of medicaments are described. The present compounds are modulators and more specifically inhibitors of the activity of 11βHSD1 and may be useful in the treatment of a range of medical disorders where a decreased intracellular concentration of active gluco-corticoid is desirable.
Owner:VTV THERAPEUTICS LLC
Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
InactiveUS20040186063A1Strong therapeutic activitySimple processCompounds screening/testingBiocideOrganic chemistryNon antibiotic
This invention features a compound of the following formula: T-(-L-C)m, T is a transportophore, L is a bond or a linker having a molecular weight up to 240 dalton, C is a non-antibiotic therapeutic agent, and m is 1, 2, 3, 4, 5, 6, 7, or 8, in which the transportophore has an immune selectivity ratio of at least 2, the transportophore is covalently bonded to the non-antibiotic therapeutic agent via the bond or the linker, and the compound has an immune selectivity ratio of at least 2.
Owner:MERCKLE GMBH DE
Rhodococcus ruber and application thereof in degradation of organic pollutants
The invention discloses rhodococcus ruber FQ-2 and an application thereof in degradation of acetone and other common industrial organic pollutants. The application method comprises the steps: an inorganic salt culture medium containing acetone and other common industrial pollutants is inoculated with the rhodococcus ruber FQ-2, a degradation reaction is carried out under the conditions of the temperature of 30 DEG C and the rotating speed of 160 r / min, and thus the organic pollutants are degraded; the common organic pollutants comprise acetone, n-hexane, carbon disulfide, chlorobenzene, butylacetate, ethyl acetate or alpha-pinene. The rhodococcus ruber FQ-2 is taken from activated sludge of an aeration tank of a pharmaceutical factory in Zhejiang province, has good degradation effect on VOCs organic pollutants, especially acetone, and can completely convert acetone into harmless substances such as CO2, H2O, cell biomass and the like; at the same time, the bacterial strain also can degrade common industrial pollutants such as carbon disulfide and chlorobenzene in different extent, so the bacterial strain has broad application prospects in biological purification of industrial wastegas and wastewater.
Owner:ZHEJIANG UNIV OF TECH
Pure natural multi-element organic fertilizer and preparation method thereof
ActiveCN102701808APromote growthIncreased vine growthBio-organic fraction processingOrganic fertiliser preparationMedicinal herbsSoil science
The invention discloses a pure natural multi-element organic fertilizer and a preparation method thereof. In the preparation method, the pure natural multi-element organic fertilizer is produced on a large scale by taking leftover furfural residues generated in a furfural plant, leftover spent mushroom compost generated by planting mushrooms, side product plant ash generated in a biomass generating plant and medicinal material dregs generated in a pharmaceutical factory as main raw materials, and adding an organic fertilizer fermenting agent for curing at a high temperature. The organic fertilizer produced by using the method has the advantages of high efficiency, low cost, high nutrition and stable quality, the problems of waste recovery, energy saving and emission reduction can be solved, soil biological balance can be improved simultaneously, and a series of agricultural problems such as soil hardening, salinization, acidification and the like caused by long-term use of a chemical fertilizer are solved. The technical indexes of the pure natural multi-element organic fertilizer produced by using the method are fully accordant with the requirements of more than or equal to 5 percent of nitrogen-phosphorus-potassium and more than or equal to 45 percent of organic matters in the novel organic fertilizer standard NY525-2012 implemented by the National Department of Agriculture in 2012.
Owner:菏泽宝源生物工程有限公司
Benzimidazole compound and pharmaceutical use thereof
ActiveUS20100120841A1Improve bioavailabilityGood metabolic stabilityBiocideNervous disorderMetabolic stabilityAgonist
Provided is an ORL-1 receptor agonist having improved bioavailability based on superior metabolic stability and strong and high selectivity, as compared to conventional compounds. A compound represented by the formula (I) wherein each symbol is as defined in the claims.
Owner:MITSUBISHI TANABE PHARMA CORP
Contact lens packages
The invention provides a package for storing medical devices that substantially eliminates reaction of a pharmaceutical agent, antimicrobial agent or both with light, which agent is incorporated into the device or contained in a solution in which the device is packaged.
Owner:JOHNSON & JOHNSON VISION CARE INC
Method and apparatus for the coating of substrates for pharmaceutical use
InactiveUS7153538B2Reduce the possibilityApplication of coating can be accurateSuppositories deliveryPretreated surfacesEngineeringCoating materials
A method of coating a pharmaceutical substrate includes the steps of applying an active coating material to a surface of the substrate to form an active coating layer and applying a cover coating material onto the active coating layer to form a cover coating layer. The active coating layer is substantially completely covered by the cover coating layer.
Owner:GLAXO GROUP LTD
Compounds, in particular peptides, compositions comprising them and cosmetic and dermo-pharmaceutical uses
ActiveUS8697656B2Reduces “ sulfurous ” smellImprove bioavailabilityCosmetic preparationsHair cosmeticsCell-Extracellular MatrixSide chain
The present invention concerns a peptide of following formula I: R being a side chain having at least one heteroatom selected from sulfur, nitrogen and oxygen in a carbonyl form (C═O); R1 being either H or a lipophilic chain; R2 being either OH or a lipophilic chain. More particularly the present invention concerns a cosmetic composition comprising a peptide as recited above and a physiologically acceptable medium. Results on the activity of the compounds are obtained and on the general state of the skin and its appendages, in particular via the stimulation of extracellular matrix components.
Owner:SEDERMA SA
Pueraria powder processing device
Owner:CHONGQING TIANXINGZHAI PUERARIA THOMSONII FOOD CO LTD
Soft bag automatic feeding system
ActiveCN101353091ASimple structureCompact structureGripping headsPackage sterilisationProduction lineEngineering
The invention discloses a soft bag automatic bag supply system, relating to the field of pharmaceutical machines. The system comprises a main machine sending device 1 produced by soft bag heavy infusion, sterilization disk 7, sterilization disk transporting orbit 6, bag fetching device comprising a bag fetching part 2 and a bag catching servo sending mechanism 3, bag swing device comprising a bag swing part 9 and a bag swing servo sending mechanism 5 as well as a stop block 24 comprising an edge stop block 33 and a middle stop block 52. The automatic bag supply system has the advantages of simple whole structure and high disk mounting precision, can be used in soft bag heavy infusion production lines, can also be applied to soft bag automatic bag supply while sterilization during the production of large, medium and small heavy infusion soft bags, and can be used in production in various big pharmaceutical plants as well as preparation divisions of various hospitals.
Owner:HUNAN FE PHARM MASCH CO LTD
Method of cleaning or purifying elastomers and elastomeric articles which are intended for medical or pharmaceutical use
A method is disclosed for removing impurities from an elastomer intended for medical or pharmaceutical use, which includes a step of performing a first solvent extraction process on the elastomer by contacting the elastomer with a first extracting solvent in a non-supercritical state to substantially remove impurities from the elastomer, thereby leaving a residue of said first extracting solvent in the elastomer. The elastomer is there after subjected to a second solvent extraction process, by contacting the elastomer with a second extracting solvent, which is a supercritical fluid or a mixture of super critical fluids, in order to remove substantially reduce the concentration of the residue of the first extracting solvent remaining in the elastomer after the first solvent extraction process.
Owner:BESPAK
Metal fullerol and its pharmaceutical use for inhibiting tumour growth
ActiveCN1935812AReduce dosageLow toxicityHydroxy compound active ingredientsGroup 3/13 element organic compoundsAbnormal tissue growthRare earth
The invention relates to metal fullerols and its application in preparing inhibition tumor medicine. Its general formula is M@C2m(OH)x, which M can be Gd, La, etc, m=41 or 30, x is not less than 10 and less than 50; it also can be M@C2mOxHy. Compared with clinic common using cyclophosphamide, cisplatin, paclitaxel etc, the metal fullerols M@C2m(OH)x or M@C2mOxHy has the advantages of little use level, low toxicity, high tumor inhibition ratio.
Owner:INST OF HIGH ENERGY PHYSICS CHINESE ACADEMY OF SCI
Triazoles compounds with antimicrobial activity and preparation method and pharmaceutical use thereof
InactiveCN101445488AThe synthesis method is simpleRaw materials are easy to getOrganic active ingredientsOrganic chemistryMedicinal chemistryPharmaceutical Plants
The invention discloses novel triazoles compounds, whose chemical names are 3-(substituted phenyl)-1-(2,4-difluorophenyl)-2-(1,2,4-triazol-1-yl)-2-propen-1-one, 1-[3-(substituted phenyl)-1-(2,4-difluorophenyl)-2-(1,2,4-triazol-1-yl)allyl]piperidinium, 3-(substituted phenyl)-1-(2,4-difluorophenyl)-2-(1,2,4-triazol-1-yl)-2-propen-1-ol, and 1-[3-(substituted phenyl)-1-(2,4-difluoropheny)-2-(1,2,4-triazol-1-yl)proyl]piperidinium, with antimicrobial activity; further discloses the preparation method and pharmaceutical use thereof.
Owner:SOUTHWEST UNIVERSITY
Biomedical and pharmaceutical waste sterilizing systems and methods
A biomedical and pharmaceutical waste sterilization system includes a vessel comprising a treatment chamber, wherein the vessel is disposed in an open frame for support thereof and the vessel comprises an opening on a top side configured to receive biomedical waste and a shredding system to treat the biomedical waste; and a chemical loading system configured to receive liquid ozone for introduction into the treatment chamber prior to and during a treatment cycle for the biomedical waste.
Owner:ENVIRONTEK WORLDWIDE LLC
Biological straw fertilizer, and production method and application thereof
InactiveCN102718596AComprehensive nutritionFertilizer effect is stable and longFertilizer mixturesEcological environmentPotassium
The invention discloses a biological straw fertilizer, and a production method and application thereof, and belongs to the field of fertilizer. The biological straw fertilizer contains the following components: nitrogen, phosphorus and potassium (N + P2O5 + K2O); straw organic matters; and biological synergist. A single nutrient content of the nitrogen, phosphorus, potassium and straw organic is not less than 1.6-2.5%; and the biological synergist is prepared by biological fermentation on soybean straw, mung bean straw, pea straw, millet straw, barley straw, rape straw, peanut straw, capsicum rod, tomato rod and drug residue from industrial scale pharmaceutical factory. The biological straw fertilizer protected by the present invention combines effects of microbial fertilizer, and organic and inorganic fertilizer, and can protect the ecological environment. From farm to table, standard safe production of grain can be executed. Therefore, the biological straw fertilizer is a non-toxic, harmless, green and environment-friendly fertilizer.
Owner:四川宏塔生物有机肥有限公司
Pharmaceutical dispensing apparatus and method
InactiveUS7707964B2Meet the requirementsMinimize potentialLiquid surface applicatorsPharmaceutical product form changeTelecommunications networkEngineering
An apparatus and method for manufacturing a pharmaceutical dose which dispenses a variable selectable quantity of at least one pharmaceutical onto a pharmaceutical receiving medium. The quantity of the dispensed pharmaceutical(s) are controllably dispensed to customize each pharmaceutical dose to suit the needs of a particular user. The apparatus is coupled by an external telecommunication network to a remote signal source for receiving pharmaceutical quantity and type data for custom manufacturing a pharmaceutical dose. In one aspect, a replaceable cartridge contains a reservoir carrying at least one pharmaceutical component and a fluid drop generator which is mountable in the fluid dispenser. The reservoir may contain a number of separate compartments, each carrying different pharmaceutical component.
Owner:HEWLETT PACKARD DEV CO LP
Method for preparing anti-hepatitis active part from swertia main pharmaceutical plant
InactiveCN1730027ARealize industrial productionSimple methodOrganic active ingredientsDigestive systemOrganic solventReactive site
The invention provides a method for preparing hepatitis-resisting active sites mainly from medicinal herbal Swertiamarin, which comprises: (1) disintegrating and extracting in water or water hydrophilic organic solvent through backflow, filtering to obtain merged concentration liquid, freezing, centrifugally filtrating, obtaining extract, (2) passing through macroscopic adsorption resin columns, (3) water scrubbing the resin columns, purging with 10-70% ethanol or methanol, collecting the eluent and concentrating.
Owner:青海普兰特药业有限公司
Functionalized polymer nanoparticles and the pharmaceutical use thereof
InactiveUS20130136714A1Improve stabilityImprove hydrophobicityMaterial nanotechnologyAntipyreticNanoparticleAtom-transfer radical-polymerization
PEO-PPO-PEO polymers and vinyl monomers are used to prepare several block copolymers via consecutive atom transfer radical polymerization (ATRP). The block copolymers provide good delivery characteristics and can be used as a gene / drug delivery carrier for therapy and diagnosis.
Owner:KAOHSIUNG MEDICAL UNIVERSITY
Small interfering nucleic acid and medical composite and pharmaceutical applications of nucleic acid
ActiveCN102140461BIncrease serum stabilityLow cytotoxicityGenetic material ingredientsAntiviralsCytotoxicityDrug biological activity
The invention provides small interfering nucleic acid of which sequences are as follows: the sequence of the sense strand is 5'-CCUUGAGGCAUACUUCAAAdTdT-3' and the sequence of the anti-sense strand is 5'-UUUGAAGUAUGCCUCAAGGdTdT-3'. The small interfering nucleic acid has the modifications shown from A1 to A5. The invention also provides a medical composite used for preventing and / or curing hepatitis B and the medical composite contains the small interfering nucleic acid provided by the invention and uses the nucleic acid as the active component. The invention also provides the applications of the small interfering nucleic acid in preparations of medicines for preventing and / or curing hepatitis B. Through the specific modifications, the aim of increasing the serum stability of the small interfering nucleic acid can be achieved under the condition of only introducing a small amount of modifications, thus the potential cytotoxicity of the modified small interfering nucleic acid molecule can be reduced and the influence on the biological activity can be lowered.
Owner:SUZHOU RIBO LIFE SCIENCE CO LTD
Pharmaceutical tablets with diffractive microstructure and compression tools for producing such tablets
A tablet (4) for pharmaceutical use has on at least one part of its surface a diffractive microstructure (11) which generates diffraction effects which can be perceived in the visible spectral range and which serve as visual safety feature. The tablet (4) consists of a plurality of individual powder particles, where the diffractive microstructures (11) are impressed into the surface of the individual powder particles. A compression tool (1, 1a, 1b, 3) to produce such tablets (4) has on one pressing surface of the compression tool (1, 1a, 1b, 3) micro-structures (11), where said microstructures (11) have dimensions which are smaller than the dimensions of the individual crystallites (30) of the material of the pressing surface of the compression tool (1, 1a, 1b, 3). The micro-structures (11) of the compression tool can be produced for example by ion etching or by imprinting.
Owner:CSEM CENT SUISSE DELECTRONIQUE & DE MICROTECHNIQUE SA RECH & DEV
SiRNA (Small interference ribonucleic acid) as well as medicine composition and pharmaceutical application thereof
ActiveCN102140459AIncrease serum stabilityLow cytotoxicityGenetic material ingredientsAntiviralsSerum igeMedicine
The invention provides a siRNA (small-interference ribonucleic acid) which has the following sequences: a sense strand of 5'-GGAAACUACUGUUGUUAGAdTdT-3' and an antisense strand of 5'-UCUAACAACAGUAGUUUCCdTdT-3'; and the siRNA has modification from one of the modes shown in E1 to E8. The invention also provides a medicine composition for preventing and / or treating hepatitis B, which contains the siRNA provided in the invention as active constituents. The invention also provides an application of the siRNA in preparing medicaments for preventing and / or treating the hepatitis B. With specific modification, the purpose of increasing the serum stability of the siRNA can be achieved by only introducing a little modification so that the modified siRNA potential cytotoxicity and influences on biological activity are reduced.
Owner:SUZHOU RIBO LIFE SCIENCE CO LTD
Positive allosteric modulators of the nicotinic acetylcholine receptor
InactiveUS20080132551A1High activityEnhance the activity of the α7 nAChRBiocideSenses disorderDiseaseAllosteric modulator
Owner:PFIZER INC
Compositions and methods for large-scale in vitro plant bioculture
InactiveUS20200383331A1Increases quantity and qualityLow costBiocideGrowth substratesBiotechnologyHemp plant
The present invention provides media, kits, systems, and methods for achieving large scale pistachio production within a short time via bioculture, large scale yam production within a short time via bioculture, high multiplication rate of plants including cannabis via in vitro micropropagation, high induction rates of somatic embryos from later buds in bamboo, reduced production of phenolic compounds in plants, high production of virus-free plants, including potato, and large scale hemp production via culturing. The present invention for pistachio and yam production results in shorter tuber development phase and higher yield. In some embodiments, the present invention provides compositions, methods, and systems for the micropropagation and mass production of perennials, grasses, bamboos, cannabis and phyto-pharmaceutical plants as well as hemp plants. In some embodiments, the present invention provides compositions, methods, and systems for reducing the production of a phenolic by a plant, such as bamboo.
Owner:BOOSHOOT
Tricyclic compound and pharmaceutical use thereof
The present invention provides a compound represented by the formulawherein R1 is a hydrocarbon group optionally having substituent(s), amino optionally having substituent(s), hydroxy optionally having a substituent or a heterocyclic group optionally having substituent(s), R2 is a hydrogen atom or a hydrocarbon group optionally having substituent(s), R3 is a hydrogen atom, a halogen atom, a hydrocarbon group optionally having substituent(s), amino optionally having substituent(s), hydroxy optionally having a substituent or mercapto optionally having a substituent, Xa, Xb, Xc and Xd are each a carbon atom or a nitrogen atom, provided that any one or two of Xa, Xb, Xc and Xd is / are nitrogen atom(s), m is 0 to 2, and rings A to C are each a ring optionally having substituent(s), or a salt thereof, which is useful as an agent for the prophylaxis or treatment of a disease relating to an action of melatonin, and the like.
Owner:TAKEDA PHARMA CO LTD
Method for preparing organic fertilizer for tea by fermentation of solid wastes of traditional Chinese medicine residues and the like
InactiveCN109320336AIncrease productionImprove qualityBio-organic fraction processingExcrement fertilisersAnimal fecesPoultry manure
The invention discloses a method for preparing organic fertilizer for tea by fermentation of solid wastes of traditional Chinese medicine residues and the like. The method comprises the following steps of uniformly mixing traditional Chinese medicine residue sections, fermenting bacteria, traditional Chinese medicine residues, vinasse, crop straws or livestock and poultry manure, preparing compostraw materials with certain ratios of C / N (carbon / nitrogen) and C / P (carbon / phosphor), and fermenting twice, so as to obtain the organic fertilizer for the tea. The prepared organic fertilizer for thetea has the characteristics that the fertilizer effect is stable, humus and various nutritional elements are rich, and the pollution is avoided; the quality of the tea is improved. The preparation method of the special fertilizer for the tea is an innovative project with small investment, short cycle, quick effect, and circulating and sustainable features; the technical resources of reutilized wastes are provided for pharmaceutical factories, wine factories, farmers, livestock farms and the like; the development space is broad, and the market prospect is good.
Owner:梁忠顺
Asafetida extract and its pharmaceutical use
InactiveCN1548037AGood application effectOdor maskingOrganic compounds purification/separation/stabilisationNervous disorderFencholHeroin
The present invention is asafetida extract and its pharmaceutical use, and aims at eliminating offensive odor of asafetida and providing one new use. The asafetida extract contains alpha-terpinene, 2-borneol, terpine tetraol, D-fenchol, pinocarveol, etc. and is extracted via conventional process. The asafetida extract is used in preparing drug addiction stopping medicine, and the medicine may be injection, capsule, tablet or granule.
Owner:王彦丁 +1
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com